Literature DB >> 12800229

Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

Shu Zheng1, Ming-Yong Han, Zuo-Xiang Xiao, Jia-Ping Peng, Qi Dong.   

Abstract

AIM: To clarify the association of vascular endothelial growth factor (VEGF) and microvascular density (MVD) expression with the angiogenesis and prognosis of colorectal cancer.
METHODS: A total of 97 cases of colorectal carcinomas were examined by immunohistochemical staining (SP method), using anti-VEGF and anti-factor CD34(+) monoclonal antibodies.
RESULTS: VEGF positive staining was obtained in 68 out of 97 cases (70.1 %), and observed mainly in the cytoplasm of tumor cells, and also frequently in stromal cells. VEGF expression was more intense in poorly differentiated adenocarcinoma in comparison with others, but there was no significant correlation between VEGF expression and age, sex and stage. A significant correlation was found between the MVD and grades, and there was no significant relationship between the MVD and age, sex, and stage. The MVD in the VEGF positive group (68 cases) was higher than that in the negative group. Upon multivariate analysis, the significant variables were stage, tumor grade and MVD; VEGF expression was not an independent prognostic factor.
CONCLUSION: The expression of VEGF has a significant correlation with MVD; MVD expression has prognostic value but VEGF has not in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800229      PMCID: PMC4611789          DOI: 10.3748/wjg.v9.i6.1227

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.

Authors:  J S de Jong; P J van Diest; P van der Valk; J P Baak
Journal:  J Pathol       Date:  1998-01       Impact factor: 7.996

2.  The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.

Authors:  K Inoue; J W Slaton; T Karashima; C Yoshikawa; T Shuin; P Sweeney; R Millikan; C P Dinney
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

3.  Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study.

Authors:  C Neuchrist; C Quint; A Pammer; M Burian
Journal:  Acta Otolaryngol       Date:  1999       Impact factor: 1.494

4.  Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcomas.

Authors:  S Kawauchi; T Fukuda; M Tsuneyoshi
Journal:  Oncol Rep       Date:  1999 Sep-Oct       Impact factor: 3.906

5.  The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia.

Authors:  S T Traweek; P L Kandalaft; P Mehta; H Battifora
Journal:  Am J Clin Pathol       Date:  1991-07       Impact factor: 2.493

6.  Angiogenic factors in laryngeal carcinomas: do they have prognostic relevance?

Authors:  M Burian; C Quint; C Neuchrist
Journal:  Acta Otolaryngol       Date:  1999-03       Impact factor: 1.494

7.  Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.

Authors:  D Strohmeyer; C Rössing; A Bauerfeind; O Kaufmann; H Schlechte; G Bartsch; S Loening
Journal:  Prostate       Date:  2000-11-01       Impact factor: 4.104

8.  The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma.

Authors:  H Guang-Wu; M Sunagawa; L Jie-En; S Shimada; Z Gang; Y Tokeshi; T Kosugi
Journal:  Laryngoscope       Date:  2000-12       Impact factor: 3.325

9.  Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.

Authors:  O N El-Assal; A Yamanoi; Y Soda; M Yamaguchi; M Igarashi; A Yamamoto; T Nabika; N Nagasue
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

10.  In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis.

Authors:  S Uchida; Y Shimada; G Watanabe; H Tanaka; I Shibagaki; T Miyahara; S Ishigami; M Imamura
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

View more
  37 in total

1.  Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer.

Authors:  Shuji Iida; Hirotoshi Hasegawa; Koji Okabayashi; Konosuke Moritani; Makio Mukai; Yuko Kitagawa
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues.

Authors:  Shao-Hua Peng; Hong Deng; Jian-Feng Yang; Ping-Ping Xie; Cheng Li; Hao Li; De-Yun Feng
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

3.  The intratumoral microvessel density and expression of bFGF and nm23-H1 in colorectal cancer.

Authors:  Sahande Elagoz; Reyhan Egilmez; Ayhan Koyuncu; Ahmet Muslehiddinoglu; Sema Arici
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

4.  Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors.

Authors:  Luciana Regina Moreira; André Almeida Schenka; Paulo Latuf-Filho; André Lisboa Penná; Carmen S P Lima; Fernando Augusto Soares; Miriam Aparecida Silva Trevisan; José Vassallo
Journal:  Tumour Biol       Date:  2011-01-08

5.  Decreased peritherapeutic VEGF expression could be a predictor of responsiveness to first-line FOLFIRI plus bevacizumab in mCRC patients.

Authors:  Hsiang-Lin Tsai; Chih-Hung Lin; Ching-Wen Huang; I-Ping Yang; Yung-Sung Yeh; Wen-Hung Hsu; Jeng-Yih Wu; Chao-Hung Kuo; Fan-Ying Tseng; Jaw-Yuan Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  Prognostic factors in 165 elderly colorectal cancer patients.

Authors:  Ke-Jun Nan; Hai-Xia Qin; Guang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Predictive value of vascular endothelial growth factor overexpression in early relapse of colorectal cancer patients after curative resection.

Authors:  Hsiang-Lin Tsai; I-Ping Yang; Chih-Hung Lin; Chee-Yin Chai; Yu-Ho Huang; Chin-Fan Chen; Ming-Feng Hou; Chao-Hung Kuo; Suh-Hang Juo; Jaw-Yuan Wang
Journal:  Int J Colorectal Dis       Date:  2012-09-09       Impact factor: 2.571

8.  Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer.

Authors:  Ye-Jiang Zhou; Yu-Xia Xiong; Xiao-Ting Wu; De Shi; Wei Fan; Tong Zhou; Yue-Chun Li; Xiong Huang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Prognostic value of microvascular density in dukes a and B (t1-t4, n0, m0) colorectal carcinomas.

Authors:  Rafael Uribarrena A; Javier Ortego; Javier Fuentes; Nuria Raventós; Pilar Parra; Rafael Uribarrena E
Journal:  Gastroenterol Res Pract       Date:  2009-11-04       Impact factor: 2.260

10.  Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.

Authors:  A M Jubb; H Turley; H C Moeller; G Steers; C Han; J-L Li; R Leek; E Y Tan; B Singh; N J Mortensen; I Noguera-Troise; F Pezzella; K C Gatter; G Thurston; S B Fox; A L Harris
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.